Solventum Corporation (SOLV)
66.95
1.05 (1.59%)
At close: Apr 24, 2025, 12:08 PM
1.59% (1D)
| Bid | 66.65 |
| Market Cap | 11.58B |
| Revenue (ttm) | 8.25B |
| Net Income (ttm) | 478M |
| EPS (ttm) | 2.76 |
| PE Ratio (ttm) | 24.26 |
| Forward PE | 10.91 |
| Analyst | Hold |
| Ask | 66.95 |
| Volume | 113,768 |
| Avg. Volume (20D) | 1,179,396 |
| Open | 66.30 |
| Previous Close | 65.90 |
| Day's Range | 65.99 - 66.95 |
| 52-Week Range | 47.16 - 85.92 |
| Beta | 0.32 |
About SOLV
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management...
Industry Medical - Care Facilities
Sector Healthcare
IPO Date Apr 1, 2024
Employees 22,000
Stock Exchange NYSE
Ticker Symbol SOLV
Website https://www.solventum.com
Analyst Forecast
According to 9 analyst ratings, the average rating for SOLV stock is "Hold." The 12-month stock price forecast is $82, which is an increase of 22.49% from the latest price.
Stock ForecastsNext Earnings Release
Solventum Corporation is scheduled to release its earnings on May 8, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-4.42%
Solventum shares are trading lower. The company re...
Unlock content with
Pro Subscription
1 month ago
+9.54%
Solventum shares are trading higher after the company announced Thermo Fisher will acquire its purification and filtration business for $4.1 billion in cash.
